Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy.
National Institutes of Health, Bethesda, MD andrew.mammen@nih.gov.
Andrew L
AL
Mammen
Eleni
E
Tiniakou
D001327:Autoimmune Diseases / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced / Q000188:drug therapy*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D016756:Immunoglobulins, Intravenous